10.3390/nu14153115 8 AshrafizadehM.AhmadiZ.MohammadinejadR.FarkhondehT.SamarghandianS
If it has been more than a fortnight, simply drop us a message through your account
The subsequent success of GLP-1 receptor agonists, despite early gastrointestinal intolerance and safety concerns, illustrates how such signals may be manageable through improved formulation and dosing rather than indicative of fundamental biological unsuitability
As semaglutide rose in popularity last year, a small number of users reported suicidal thoughts while taking it
A 2026 UK evidence review of TPO antibodies, the T3-BDNF-HGF axis, NICE NG145, levothyroxine, T3 liothyronine and Hashimoto's Read the full review Neuroscience 29 May 2026 Dihexa for Lupus (SLE) Brain Fog & Neuropsychiatric Lupus (NPSLE): The 2026 UK Review Rigorous 2026 UK review of Dihexa for lupus (systemic lupus erythematosus, SLE) brain fog and neuropsychiatric lupus (NPSLE)